The Food and Drug Administration is helping the United Nations figure out how to categorize cannabidiol (CBD). I’ve used this blog as a means to tout the benefits of CBD many times. Even have wondered whether the FDA would ever get on board to study the value. It seemed especially impossible in light of the DEA’s (US Drug Enforcement Administration) December 2016 attempt to call CBD a Schedule I substance. Schedule I drugs, by definition, have “no currently accepted medical use in treatment in the United States.”
Given the current administration’s sentiment toward hemp and anything remotely related to marijuana, I didn’t hold out a lot of hope for quick action.
I was wrong. The FDA has openly stated that CBD has been shown to be beneficial. Finally. But, even more important, it’s asking for your feedback by September 13. So, if you’ve ever used CBD in any form for medical or health purposes, you could visit the website either anonymously or provide your contact information, and let the FDA know about your experience.
As you might expect, the website has a lot of information, but you can skim it and select the comment now button on the top right. At this point, more than 1,000 people have left comments, including me.
So, the ball’s in your court.